Please login to the form below

Not currently logged in
Email:
Password:

RRMS

This page shows the latest RRMS news and features for those working in and with pharma, biotech and healthcare.

Novartis files for approval of MS drug in EU, US

Novartis files for approval of MS drug in EU, US

Around a quarter of patients with RRMS go onto develop SPMS within 10 years of their initial diagnosis. ... That’s the same mechanism as $3bn-a-year product Gilenya, which is approved to treat RRMS but didn’t hit the mark in SPMS trials.

Latest news

More from news
Approximately 8 fully matching, plus 29 partially matching documents found.

Latest from PMHub

  • Innovative approaches in the treatment of multiple sclerosis

    THE TWO TYPES OF MS. There are two main clinical presentations of MS – Relapsing Refractory MS (RRMS) and Progressive MS (PMS). ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and longer-lasting as the disease

  • Innovative approaches in the treatment of multiple sclerosis

    THE TWO TYPES OF MS. There are two main clinical presentations of MS – Relapsing Refractory MS (RRMS) and Progressive MS (PMS). ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and longer-lasting as the disease

  • It's time to change the conversation

    Take Multiple Sclerosis (MS) for example. MS has four different disease manifestations: Relapsing Remitting (RRMS), Secondary Progressive (SPMS), Primary Progressive (PPMS) and Progressive Relapsing (PRMS). ... Today however, given the research and the

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics